Trademark: 90770177
Word
F
Status Date
Tuesday, June 20, 2023
Filing Date
Friday, June 11, 2021
Published for Opposition
Tuesday, October 25, 2022
5 Injectable pharmaceuticals and gene therapies for treatment of metabolic conditions, diseases and disorders, liver conditions, diseases and disorders, and diabetes
10 medical instruments for use in minimally invasive procedures and surgery; Medical apparatus for use in minimally invasive procedures and surgery; Injectable devices for pharmaceuticals and gene therapies for treatment of metabolic conditions, diseases and disorders, liver conditions, diseases and disorders, and diabetes; Medical instruments for use in minimally invasive procedures and surgery in the field of endoscopy; Medical systems comprised of surgical apparatus, medical instruments, and medical components in the nature of medical needles, medical instruments in the nature of fluid jets for use in minimally invasive medical or surgical procedures, iontophoretic elements in the nature of medical electrodes and drug delivery patches sold without medication, and medical instruments in the nature of porous membranes for use in minimally invasive medical or surgical procedures, all for use in fluid delivery and for medical purposes; medical instruments for use in minimally invasive procedures and surgery for fluid delivery; catheters; medical and surgical catheters; catheters and parts and fittings therefor; needles for medical use; needles for medical purposes; injection needles; needle-based injection system for injecting medical fluids
42 Medical research; research and development of medical and surgical procedures; research and development of therapeutic procedures; research and development of minimally invasive and surgical procedures to treat metabolic disease and disorders; research and development of medical procedures with therapeutic metabolic benefits; research and development of minimally invasive procedures and surgery in the field of endoscopy; research and development of therapeutic procedures utilizing gene therapy; research and development of medical and surgical procedures utilizing gene therapy; research and development of minimally invasive and surgical procedures utilizing gene therapy
The mark consists of stylized "F" within a circle.
FRACTYL
Feb 6, 2024
Case Assigned To Intent To Use Paralegal
Dec 19, 2023
Teas Request To Divide Received
Jan 10, 2024
Case Assigned To Intent To Use Paralegal
Dec 19, 2023
Sou Teas Extension Received
Dec 19, 2023
Teas Statement Of Use Received
Jun 22, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 20, 2023
Sou Extension 1 Granted
Jun 20, 2023
Sou Extension 1 Filed
Jun 20, 2023
Sou Teas Extension Received
Dec 20, 2022
Noa E-Mailed - Sou Required From Applicant
Oct 25, 2022
Official Gazette Publication Confirmation E-Mailed
Oct 25, 2022
Published For Opposition
Oct 5, 2022
Notification Of Notice Of Publication E-Mailed
Sep 20, 2022
Approved For Pub - Principal Register
Sep 6, 2022
Teas/Email Correspondence Entered
Sep 6, 2022
Correspondence Received In Law Office
Sep 6, 2022
Teas Response To Office Action Received
Mar 4, 2022
Notification Of Non-Final Action E-Mailed
Mar 4, 2022
Non-Final Action E-Mailed
Mar 4, 2022
Non-Final Action Written
Feb 25, 2022
Assigned To Examiner
Sep 2, 2021
Notice Of Design Search Code E-Mailed
Sep 1, 2021
Automatic Update Of Assignment Of Ownership
Sep 1, 2021
New Application Office Supplied Data Entered
Jun 15, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
